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GENERAL REPORT 
 
The overall mortality in acute pancreatitis remains 5-10%, and may increase to 
30% or higher if complications develop. This unacceptably high mortality is due to the 
lack of specific treatments for the disease. In this project we provided experimental 
justification for the hypothesis that pancreatic ductal bicarbonate secretion has a 
protective effect for the entire exocrine pancreas during noxious stress such as biliary 
stones or ethanol abuse. The results of this project may open up the possibility of 
pharmacological therapy of acute pancreatitis leading to reduced morbidity and 
mortality (Hegyi et al., Am J Gastro, 2010, Hegyi et al., Gut, 2011).  
 
DETAILED REPORT 
 
Our results showed that (i) a high dose of the non-conjugated 
chenodeoxycholate (CDC), but not the conjugated gluco chenodeoxycholate 
(GCDC), causes mitochondrial damage followed by (ATP)i depletion and (ii) the 
(ATP)i depletion by itself can be responsible for the impaired fluid and HCO3- 
secretion. The relationship between mitochondrial function and HCO3- secretion and 
the differences between the effects of conjugated and non-conjugated bile acids 
needs further investigation (Maléth J et al., Gut, 2011; Hegyi P et al., Gut, 2011)  . 
We have demonstrated the pathophysiological importance of apical maxiK+ 
(BK) channels in PDEC. Activation of apical BK channels alone stimulates pancreatic 
ductal HCO3- secretion and importantly, plays a crucial role in the stimulatory effect of 
CDC on HCO3- secretion. Our data suggest that activation of BK channels by 
synthetic compounds may represent a new therapeutic approach to protect the 
pancreas in acute pancreatitis (Venglovecz V et al., Gut, 2011). 
In our trypsin study, we showed for the first time that (i) PAR-2 is localized to 
the apical membrane of the human proximal PDEC, (ii) the localization of PAR-2 in 
the guinea pig pancreas is identical to the human gland, (iii) trypsin markedly reduces  
bicarbonate efflux through a dihydro-4,4’-diisothiocyanostilbene-2,2’-disulfonic acid 
(H2DIDS)-sensitive apical SLC26 anion exchanger and strongly inhibits CFTR, (iv) 
that a decrease in pH within the ductal lumen will strongly accelerate the 
autoactivation of trypsinogen, and (v) trypsin down-regulates PAR-2 expression by 
PDEC in patients suffering from all forms of pancreatitis (Pallagi P et al., Gastroenterology, in 
revision)
.   
We characterized a novel model of severe necrotizing acute pancreatitis 
induced by L-lysine. The results of this study, in combination with our previous data, 
indicate that basic amino acids, L-lysine, L-arginine and L-ornithine all injure the 
exocrine pancreas resulting in pancreatitis. Our data demonstrate that L-lysine 
impairs ATP synthase activity of pancreatic mitochondria. This occurs early in the 
development of the disease and is followed by trypsinogen and NF-kB activation 
inflammatory infiltration, and acinar cell death through apoptosis and necrosis. 
Importantly, L-lysine selectively damages pancreatic mitochondria, it had no effect on 
liver mitochondria. The data strongly suggest that mitochondrial damage is a cause 
of pancreatitis induced by L-lysine (Biczo G et al., Antiox & Redox, 2011). 
 We have also shown evidences that the relationship between the 
iontransporters and inflammatory disorders are not organ specific and it could be true 
in the whole GI tract (Yeruva S et al., IBD, 2011; Farkas K et al., IBD, 2011). 
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